Attending this event?
Back To Schedule
Monday, June 20 • 1:30pm - 2:30pm
#121: Identifying Value and Driving Access to Drug-Based Products Evaluated Using Digital Endpoints

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Application UAN: 0286-0000-22-523-L04-P ; CME 1.00; RN 1.00

This forum will discuss case studies from the US, Europe, and Asia to present a framework developed as part of a multi-stakeholder effort that supports a transparent, consistent, and patient-centered decision process for digital endpoints as value-evidence for reimbursing drug-based products.

Learning Objectives

Identify roadblocks/misaligned incentives across stakeholders evaluating information derived from digital endpoints used in drug development; Define shared terminology surrounding value of evidence of drug-based product efficacy derived from digital endpoints; Demonstrate value of evidence of drug-based product efficacy derived from digital endpoints across stakeholders/global regions.


Smit Patel, PharmD


Patient Perspective
Mariah Leach, JD, MS

Industry Perspective
Jiat Ling Poon, PhD

Payer Perspective
Siavash Sarlati, MD

avatar for Mariah Leach

Mariah Leach

Founder, Patient Advocate, Mamas Facing Forward, United States
Mariah is a writer, patient advocate, and mom of three living with rheumatoid arthritis. After learning firsthand the challenges of facing pregnancy and motherhood with a chronic illness, Mariah has become passionate about supporting women with chronic illnesses who are or want to... Read More →
avatar for Smit Patel

Smit Patel

Clinical Innovation Lead, Digital Medicine Society (DiMe), United States
Dr. Smit J. Patel, PharmD serves as the Clinical Innovation Lead at the Digital Medicine Society (DiMe), a 501(c)(3) global non-profit organization dedicated to better health powered by digital medicine. Smit’s work focuses on applied approaches to the safe, effective, ethical... Read More →
avatar for Jiat Ling Poon

Jiat Ling Poon

Director, Value, Evidence, and Outcomes, Eli Lilly and Company, United States
Jiat Ling (Jiat) Poon is a Director in Value, Evidence, and Outcomes at Eli Lilly and Company, responsible for the development of innovative and efficient patient-focused endpoints and measurement strategies to support drug development across Lilly’s portfolio. Jiat has over 8 years... Read More →

Siavash Sarlati

Medical Director, Digital Technology, Anthem, Inc., United States
Siavash Sarlati is a practicing Emergency Physician who serves as medical director for Anthems Digital Platforms Devision. He provides clinical expertise for Anthem's digital health solutions development and manages the clinical evaluation of both first and third-party digital health... Read More →

Monday June 20, 2022 1:30pm - 2:30pm CDT
Room 185 CD McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  12: Value-Access, Forum